Research Article
[Retracted] Efficacy of Drug-Eluting Bead Transarterial Chemoembolization in the Treatment of Colorectal Cancer Liver Metastasis
Table 3
Analyses of side effects.
| | | TACE group n = 60 | DEB-TACE group n = 60 | value |
| | Abdominal pain | 31 (51.7%) | 18 (30.0%) | 0.025 | | Fever | 19 (31.7%) | 15 (25.0%) | 0.517 | | Nausea and vomiting | 23 (38.3%) | 20 (33.3%) | 0.416 | | Diarrhea | 24 (40.0%) | 14 (23.3%) | 0.077 | | Fatigue | 25 (41.7%) | 15 (25.0%) | 0.081 | | Leukopenia | 17 (28.3%) | 5 (8.3%) | 0.008 | | Anemia | 26 (43.3%) | 11 (18.3%) | 0.005 | | Thrombocytopenia | 22 (33.3%) | 6 (10.0%) | 0.001 | | Liver function damage | 33 (55.0%) | 16 (26.7%) | 0.003 |
|
|